|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2011-3-7
|
|
pubmed:abstractText |
The current study was conducted to compare simultaneously obtained bone marrow (BM) cytogenetics (CTG), peripheral blood (PB) and BM fluorescence in situ hybridization (FISH), and quantitative real-time polymerase chain reaction (Q-PCR) for BCR-ABL1 in monitoring response to treatment with tyrosine kinase inhibitors and homoharringtonine (HHT) in patients with chronic myeloid leukemia (CML).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
pubmed-author:ArellanoMarthaM,
pubmed-author:Bernal-MizrachiLeonL,
pubmed-author:HeffnerLeonardL,
pubmed-author:KhouryHanna JeanHJ,
pubmed-author:LangstonAmeliaA,
pubmed-author:MannKaren PKP,
pubmed-author:McLemoreMorganM,
pubmed-author:RoaV HVH,
pubmed-author:SaxeDebraD,
pubmed-author:TighiouartMouradM,
pubmed-author:WintonElliottE
|
|
pubmed:copyrightInfo |
Copyright © 2010 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
117
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1245-52
|
|
pubmed:meshHeading |
pubmed-meshheading:21381013-Adolescent,
pubmed-meshheading:21381013-Adult,
pubmed-meshheading:21381013-Aged,
pubmed-meshheading:21381013-Antineoplastic Agents,
pubmed-meshheading:21381013-Chemotherapy, Adjuvant,
pubmed-meshheading:21381013-Cytogenetic Analysis,
pubmed-meshheading:21381013-Drug Administration Schedule,
pubmed-meshheading:21381013-Female,
pubmed-meshheading:21381013-Hematologic Tests,
pubmed-meshheading:21381013-Humans,
pubmed-meshheading:21381013-Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
pubmed-meshheading:21381013-Male,
pubmed-meshheading:21381013-Middle Aged,
pubmed-meshheading:21381013-Monitoring, Physiologic,
pubmed-meshheading:21381013-Neoplasm Staging,
pubmed-meshheading:21381013-Piperazines,
pubmed-meshheading:21381013-Polymerase Chain Reaction,
pubmed-meshheading:21381013-Prognosis,
pubmed-meshheading:21381013-Pyrimidines,
pubmed-meshheading:21381013-Retrospective Studies,
pubmed-meshheading:21381013-Young Adult
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Peripheral blood monitoring of chronic myeloid leukemia during treatment with imatinib, second-line agents, and beyond.
|
|
pubmed:affiliation |
Department of Hematology and Medial Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, Georgia 30322, USA.
|
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|
